Lancet Global Health

Article	Citations
Global health research funding applications: brain drain under another name?	934
Bringing home manufacturing of medical products	375
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply	327
Influenza vaccination in failing hearts	324
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)	320
Preventing pellagra during isoniazid preventive treatment	316
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6	312
Correction to Lancet Glob Health 2021; 9: e1679–87	263
The cause of nodding syndrome remains unknown	251
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou	251
Mpox vaccination strategies in DR Congo	241
Racism and health: the need for urgent action	228
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial	217
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study	210
Is now the time for revisiting supplements for pregnant women?	176
Challenges in operationalising clinical trials in India during the COVID-19 pandemic	175
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis	167
The drug drought in maternal health: an ongoing predicament	160
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study	159
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m	157
The future of the International Health Regulations	155
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications	155
C-reactive protein: another addition to our armamentarium against tuberculosis?	153
Outcomes of rheumatic fever in Uganda: a prospective cohort study	151
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys	146

Indonesia's first nationwide health screening programme	146
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019	144
Expanding access to long-acting HIV therapy in low-income and middle-income countries	143
The road to malaria elimination: why a robust surveillance system is imperative	143
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial	139
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study	134
Global patterns and trends in Kaposi sarcoma incidence: a population-based study	134
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis	131
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study	129
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study	127
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial	124
Resolving the CD4-testing crisis to help end AIDS-related deaths	118
The health status of Indonesia's provinces: the double burden of diseases and inequality gap	118
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study	111
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study	107
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis	106
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor	105
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply	101
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr	101
Achieving sensible targets for a diabetes care cascade in LMICs	95
Mpox: evidence for strengthening and sustaining global surveillance	95
Addressing the complex needs of people with severe mental health disorders in low-resource settings	95
Pregnancy in people who have survived Ebola virus disease	91
From child institutions to family reunification: challenges and opportunities in building family-centred care	89
Lessons for future implementation of the E-MOTIVE bundle	88
Payment in arrears: a global health inequity that must be corrected	88
Addressing the social inequities of vaccination: an imperative to close the gap	87
The social determinants of tuberculosis in the Philippines	86
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research	85
Commitment and innovation on the road to people-centred PHC financing	84
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden	84
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine	84
Climate change and health: the next challenge of ethical AI	82
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation	81
Infertility—why the silence?	81
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned	78
Improving access to liposomal amphotericin B worldwide	78
Impact of excluded studies on medical male circumcision and HIV risk compensation	76
Bridging the gap between science and policy in global health governance	75
Experiences of an Israeli hospital in the management of repatriated civilian hostages	75
Using verbal autopsy to enhance mortality surveillance	75
Correction to Lancet Glob Health 2023; 11: e1978–85	74
Correction to Lancet Glob Health 2022; 10: e1443–52	74
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer	74
Staying focused on protecting young people from the harms of tobacco smoke	72
Highlighting the need for investment and innovation in ART retention interventions	72
How to DREAMM and end HIV-related deaths	71
Uncertainty in key population size estimates in sub-Saharan Africa	70
Cervical cancer elimination: actions needed in the COVID-19 era	69
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study	69

Using theory to understand how interventions work and inform future implementation	68
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis	68
Correction to Lancet Glob Health 2015; 3: e196	67
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study	67
Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995–2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023	65
Next generation economics of universal HIV treatment	64
Changes in incidence of HPV-related cancers in South Africa (2011–21): a cross-sectional analysis of the South African National Cancer Registry	64
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement	64
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial	63
Policy prioritisation to address the global burden of rheumatic heart disease	63
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition	63
Understanding deaths from diarrhoea in children younger than 5 years	63
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control	62
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security	60
Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–20	57
Cholera rapid diagnostic tests recycled for PCR confirmation	57
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all	57
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026	56
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review	55
Correction to Lancet Glob Health 2022; 10: e1115–27	54
Precision in prescription: multiple micronutrient supplements in pregnancy	54
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns	54
People who inject drugs in the Eastern Mediterranean region	52
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation	52
Migrants and displaced people: intentionally endangered and inconsistently visible	51
Withholding liberty, not the right to health	51
Lots of considerations when evaluating the FujiLAM assay – Author's reply	50
Maternal intimate partner violence and child health outcomes	50
Unveiling the crisis of the double burden of malnutrition	49
Reciprocal innovation: a new approach to equitable and mutually beneficial global health research and partnerships	49
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le	48
Equity challenges in Indonesian health care	47
Reducing antibiotic use with diarrhoeal vaccines	47
COVID-19 in pregnancy: evidence from LMICs	47
Family-based approach in cardiovascular risk reduction	47
Every baby counts: eliminating all preventable child deaths	46
Low risk, high impact: the hidden burden of cardiovascular disease	46
Characterisation of febrile non-traumatic coma in sub-Saharan Africa	46
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled t	46
Identifying gaps in the HIV treatment cascade in Africa: a model comparison study	45
Pulse oximetry to detect paediatric hypoxaemia—the fifth vital sign	45
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study	44
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipaliti	44
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries:	43
Addressing global micronutrient inadequacies: enhancing global data representation	42
Keeping an eye on eye care: monitoring progress towards effective coverage	42
AI for health or AI for war? Challenging the military partnerships behind climate harm	42
Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health	42
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) regi	42
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis	41
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data	41
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings	40
The landscape for rare diseases in 2024	40
Tuberculosis and undernutrition in India – Authors’ reply	39
Impact of excluded studies on medical male circumcision and HIV risk compensation – Authors' reply	39
The incalculable costs of tuberculosis	39
Insights from Zimbabwe's SARS-CoV-2 genomic surveillance	39
Can resistance testing improve outcomes for children and adolescents with HIV?	38
Can the ShangRing bring us closer to endorsing early infant male circumcision in sub-Saharan Africa?	38
Correction to Lancet Glob Health 2020; 8: e1186–94	38
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake	38
Universal health coverage is fundamental to preparing for a healthier and better tomorrow	38
Correction to Lancet Glob Health 2024; 12: e1389–90	37
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries	37
Avoiding another lost decade in reducing malaria burden in African infants and young children	36
Innovative methods of determining health expenditure efficiency are urgently needed	36
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem	36
Donor aid and research funding for newborn babies and preventing stillbirths	36
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study	35
The challenge of promoting physical activity in low-income and middle-income countries	35
Policy and service delivery proposals to improve primary care services in low-income and middle-income country cities	35
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study	35
Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study	34
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort	34
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region	34
Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study	34
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study	34
Homing in on haemoglobinopathies	34
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India	34
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines	34

Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort	34
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories	33
Climate change and the right to health of people with disabilities	33
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis	33
How the EAT–Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication	33
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries	33
Wastewater monitoring can anchor global disease surveillance systems	33
Finding balance in Nigeria's mandatory health insurance	32
Colorectal cancer screening with fecal immunochemical testing in Nigeria – Authors' reply	32
Uncertainty in computerised analysis of maternal deaths	32
Moving beyond standard RMNCH coverage indicators	32
Enhancing cervical and breast cancer training in Africa with e-learning	31
Defining the usefulness of oral swabs in tuberculosis diagnosis	31
Ethical considerations for introducing RTS,S/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission	31
Questions about the HELIX trial	31
Aminoglycosides, deafness, and non-tuberculous mycobacteria	31
Global variations in barriers to exercise for individuals with intellectual and developmental disability	31
Nodding syndrome and doxycycline: promising findings with open questions	31
Navigating AMR with innovative diagnostics	31
Trans Reform: an initiative for the recognition of transgender rights in a university in Lima, Peru	31
Mpox vaccination strategies in DR Congo	31
Relapse after recovery from acute malnutrition	31
Combating antimicrobial resistance in neonatal infections: a South African perspective	31
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial	30
Prevention of pneumococcal diseases: the challenge remains	30
The challenging road to universal health coverage	30
Catastrophic health expenditure and chronic respiratory disease: evidence from Kenya	30
Correction to Lancet Glob Health 2025; 13: e528–84	30
The need for a One Health approach for influenza surveillance	30
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction – Authors' reply	29
Postnatal morbidity: prevalent, enduring, and neglected	29
Correction to Lancet Glob Health 2025; 13: e309–18	29
The continuum of menstrual health through the life course	29
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial	29
Targeting malaria control to schoolchildren	29
Pragmatic global health	29
Correction to Lancet Glob Health 2022; 10: 1715–43	28
Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial	28
Neonatal mortality during the war in Tigray: a cross-sectional community-based study	28
Colorectal cancer screening in sub-Saharan Africa	28
Balancing global access to opioids	28
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action	28
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings	28
Enabling access to quality abortion care: WHO's Abortion Care guideline	28
Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries	28
The health toll of economic sanctions	27
Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): an open-label, single-centre, cluste	27
Urgent call for the prioritisation of palliative care in Syria	27
Individual-level and community-level factors for 10-year cardiovascular disease risk in Ethiopia: a retrospective, population-based, cross-sectional, observational study	27
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study	27
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial	27
Integrating mental health care to reduce intimate partner violence in complex humanitarian emergencies	27
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study	27
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research	27
Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors	26
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study	26
Indigenous and minority groups in diabetes trials	26
Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional s	26
Global, regional, and national causes of death in children and adolescents younger than 20 years: an open data portal with estimates for 2000–21	26
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study	26
National diabetes prevention programmes in LMICs are now a necessity	26
The SARS-CoV2 pandemic and routine immunisation	26
Are current systems of global health academia fit for purpose?	26
Clearing our heads over alcohol	25
Correction to Lancet Glob Health 2024; 12: e1209–13	25
Short-term aid or long-term gains? Harnessing Sudan's humanitarian response for the resilience of its health system	25
Correction to Lancet Glob Health 2024; 12: e25–27	25
Correction to Lancet Glob Health 2021; 9: e1610–17	25
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats	25
Strengthening health-care systems to reduce child mortality	25
Where are the opportunities to address system barriers preventing equitable cardiovascular outcomes for indigenous populations?	25
Obstetric fistula in Bangladesh: estimates from a national survey with clinical validation correction	25
Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators	24
Malaria guidelines fall short in diagnosing acute kidney injury	24
Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older	24
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study	24
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care	24
Peripheral artery disease: a global need for detection, prevention, and treatment	24
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models	24
Exposure to household air pollution from cooking fuel in Ugandan households and associated household factors: a retrospective analysis of demographic and health survey data	24
Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: a mathematical modelling study	24
Low-value health care in the COVID-19 pandemic	24
Prevalence and changes of intimate partner violence against women aged 15 to 49 years in 53 low-income and middle-income countries from 2000 to 2021: a secondary analysis of population-based surveys	24
COVID-19 vaccine hesitancy in Africa: a call to action	24
Estimating dementia prevalence using remote diagnoses and algorithmic modelling: a population-based study of a rural region in South Africa	24
What can we learn from developments in primary health care in south Asia?	24
Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgame	24
Why and for whom are we decolonising global health?	24
Socioeconomic inequalities in palliative care access: insights from SHARE	24
Maximising the value of nudge units for global health	24
Redefining implementation science for global health decolonisation	24
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study	23
Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectiona	23
A call to action: the global failure to effectively tackle maternal mortality rates	23
Democratising clinical trials research to strengthen primary health care	23